J. Oliver McIntyre - Publications

Affiliations: 
Cancer Biology Vanderbilt University, Nashville, TN 

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Haskett DG, Maestas D, Howerton SJ, Smith T, Ardila DC, Doetschman T, Utzinger U, McGrath D, McIntyre JO, Vande Geest JP. 2-Photon Characterization of Optical Proteolytic Beacons for Imaging Changes in Matrix-Metalloprotease Activity in a Mouse Model of Aneurysm. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 1-12. PMID 26903264 DOI: 10.1017/S1431927616000088  0.309
2015 Samuelson LE, Scherer RL, VanSaun MN, Fan KH, Dozier EA, Carter KJ, Koyama T, Shyr Y, Aschner M, Stanwood GD, Bornhop DJ, Matrisian LM, McIntyre JO. New tools for the quantitative assessment of prodrug delivery and neurotoxicity. Neurotoxicology. 47: 88-98. PMID 25732874 DOI: 10.1016/J.Neuro.2015.02.005  0.523
2013 Samuelson LE, Scherer RL, Matrisian LM, McIntyre JO, Bornhop DJ. Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Molecular Pharmaceutics. 10: 3164-74. PMID 23750801 DOI: 10.1021/Mp4002206  0.541
2012 Samuelson LE, Scherer RL, Kathy CJ, Dozier EA, Printz S, VanSaun MN, Fan K, Shyr Y, Matrisian PE, Bornhop DJ, Matrisian LM, McIntyre JO. Abstract 1947: Self-reporting dendritic nanoparticles (nanodendrons) for drug delivery targeted to the tumor microenvironment and with reduced neurotoxicity Cancer Research. 72: 1947-1947. DOI: 10.1158/1538-7445.Am2012-1947  0.329
2011 Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. Plos One. 6: e22775. PMID 21857953 DOI: 10.1371/journal.pone.0022775  0.405
2010 Uddin MJ, Crews BC, Blobaum AL, Kingsley PJ, Gorden DL, McIntyre JO, Matrisian LM, Subbaramaiah K, Dannenberg AJ, Piston DW, Marnett LJ. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. Cancer Research. 70: 3618-27. PMID 20430759 DOI: 10.1158/0008-5472.Can-09-2664  0.526
2010 McIntyre JO, Scherer RL, Matrisian LM. Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 622: 279-304. PMID 20135290 DOI: 10.1007/978-1-60327-299-5_18  0.577
2010 Soebbing S, Tantawy MN, Baldwin RM, Peterson TE, Matrisian LM, McIntyre JO. Noninvasive in vivo imaging of MMP-7 activity Nuclear Medicine and Biology. 37: 708. DOI: 10.1016/J.Nucmedbio.2010.04.010  0.549
2009 McIntyre JO, Matrisian LM. Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 539: 155-74. PMID 19377965 DOI: 10.1007/978-1-60327-003-8_9  0.571
2008 Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Molecular Imaging. 7: 118-31. PMID 19123982 DOI: 10.2310/7290.2008.00010  0.558
2008 Lebel R, Jastrzebska B, Therriault H, Cournoyer MM, McIntyre JO, Escher E, Neugebauer W, Paquette B, Lepage M. Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model. Magnetic Resonance in Medicine. 60: 1056-65. PMID 18956456 DOI: 10.1002/Mrm.21741  0.322
2008 Martin MD, Fingleton B, Lynch CC, Wells S, McIntyre JO, Piston DW, Matrisian LM. Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth. Clinical & Experimental Metastasis. 25: 877-85. PMID 18787962 DOI: 10.1007/S10585-008-9206-Y  0.48
2008 Quarles CC, Lepage M, Gorden DL, Fingleton B, Yankeelov TE, Price RR, Matrisian LM, Gore JC, McIntyre JO. Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 718-26. PMID 18727087 DOI: 10.1002/Mrm.21724  0.448
2008 Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Reviews. 27: 679-90. PMID 18465089 DOI: 10.1007/S10555-008-9152-9  0.592
2008 Dive V, Paulick MG, McIntyre JO, Matrisian LM, Bogyo M. Activity-based imaging and biochemical profiling tools for analysis of the cancer degradome The Cancer Degradome: Proteases and Cancer Biology. 101-135. DOI: 10.1007/978-0-387-69057-5_7  0.492
2007 Lepage M, Dow WC, Melchior M, You Y, Fingleton B, Quarles CC, Pépin C, Gore JC, Matrisian LM, McIntyre JO. Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Molecular Imaging. 6: 393-403. PMID 18053410 DOI: 10.2310/7290.2007.00035  0.563
2007 Piston D, Uddin M, McIntyre J, Crews B, Head W, Wells K, Matrisian L, Marnett L. Quantitative Optical Imaging of Molecular Signals from Cancerous Cells in vivo Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607072819  0.481
2006 Menon R, McIntyre JO, Matrisian LM, Fortunato SJ. Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes. American Journal of Obstetrics and Gynecology. 194: 1609-15; discussion . PMID 16731078 DOI: 10.1016/J.Ajog.2006.02.052  0.426
2005 Harrell PC, McCawley LJ, Fingleton B, McIntyre JO, Matrisian LM. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Experimental Cell Research. 303: 308-20. PMID 15652345 DOI: 10.1016/J.Yexcr.2004.09.020  0.516
2004 Fingleton B, Menon R, Carter KJ, Overstreet PD, Hachey DL, Matrisian LM, McIntyre JO. Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7865-74. PMID 15585619 DOI: 10.1158/1078-0432.Ccr-04-1252  0.502
2004 McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. The Biochemical Journal. 377: 617-28. PMID 14556651 DOI: 10.1042/Bj20030582  0.54
2003 McIntyre JO, Matrisian LM. Molecular imaging of proteolytic activity in cancer. Journal of Cellular Biochemistry. 90: 1087-97. PMID 14635184 DOI: 10.1002/Jcb.10713  0.557
Show low-probability matches.